NCT07308730 Pain Diary Use After Laparoscopic Cholecystectomy
| NCT ID | NCT07308730 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Muğla Sıtkı Koçman University |
| Condition | Cholelithiasis |
| Study Type | INTERVENTIONAL |
| Enrollment | 142 participants |
| Start Date | 2025-11-15 |
| Primary Completion | 2026-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 142 participants in total. It began in 2025-11-15 with a primary completion date of 2026-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled study aims to evaluate the effectiveness of using a pain diary in the assessment of early postoperative pain in patients undergoing laparoscopic cholecystectomy. Patients will be randomly assigned to a pain diary group or a control group receiving routine pain assessment. Postoperative pain intensity will be measured at predefined time points using standardized pain assessment tools. The study seeks to improve patient participation in postoperative pain evaluation without introducing additional pharmacological interventions.
Eligibility Criteria
Inclusion Criteria: 1. Admitted for elective laparoscopic cholecystectomy 2. Scheduled for first-time laparoscopic cholecystectomy 3. Aged 18 years or older 4. Able to speak, read, and understand Turkish 5. Literate 6. Communicative and cooperative 7. ASA score of 1, 2, or 3 8. Expected to stay at least 24 hours in the hospital post-surgery 9. Capable of understanding study instructions 10. Willing to participate voluntarily Exclusion Criteria: 1. Prolonged stay in the recovery unit due to extended effects of general anesthesia 2. Admission to intensive care unit postoperatively 3. Having chronic pain and receiving treatment for it 4. Being a cancer patient 5. Having a writing disability 6. Inability to communicate 7. Having cognitive, affective, verbal, visual, or auditory impairments 8. Diagnosed psychiatric disorders such as anxiety or depression and using related medications 9. Choosing to withdraw from the study after giving consent
Contact & Investigator
Gülşah K KÖSE
STUDY DIRECTOR
Muğla Sıtkı Koçman University / Faculty of Health Sciences Department of Nursing
Frequently Asked Questions
Who can join the NCT07308730 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cholelithiasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07308730 currently recruiting?
Yes, NCT07308730 is actively recruiting participants. Contact the research team at aslanmuhammed282@gmail.com for enrollment information.
Where is the NCT07308730 trial being conducted?
This trial is being conducted at Muğla, Turkey (Türkiye).
Who is sponsoring the NCT07308730 clinical trial?
NCT07308730 is sponsored by Muğla Sıtkı Koçman University. The principal investigator is Gülşah K KÖSE at Muğla Sıtkı Koçman University / Faculty of Health Sciences Department of Nursing. The trial plans to enroll 142 participants.